Fadie Thomas Coleman

Assistant Professor, Medical Sciences & Education

Fadie Coleman


Dr. Coleman is an assistant professor at the Boston University School of Medicine (BUSM). She received her doctorate from the BUSM Department of Microbiology, and completed her postdoctoral fellowship at the Boston Children’s Hospital in the Department of Pathology/Transfusion Medicine. She is trained in both the biomedical sciences and science pedagogy. As a microbiologist, Dr. Coleman’s research focuses on bacterial pathogens. She has served as principal investigator and collaborator with other investigators on several projects and has published in a wide range of peer-reviewed journals, including Journal of Infectious Diseases, Mucosal Immunology, and Proceedings of the National Academy of Sciences. She has been invited to give several professional seminars at national and international meetings, including the mini-symposia at the American Thoracic Society International Conference in San Diego, California. Dr. Coleman is also the recipient of numerous awards for research excellence, including a National Research Service Award Fellowship from the National Institutes of Health, the BU President’s Award for Outstanding Biomedical Research, and the 2014 Raymond W. Sarber Award.

Dr. Coleman is also the director of the Biomedical Laboratory and Clinical Sciences program, the medical school’s only degree granting undergraduate program in the biomedical sciences. As an educator and researcher, Dr. Coleman draws from her previous K-12 and higher education teaching experiences and training to establish new and innovative strategies designed to prepare undergraduates (especially from underrepresented backgrounds) to enter and succeed in the biomedical/STEM workforce. Her specific areas of science education research are: 1) educational interventions that enhance diversity and equity in science education; 2) effective learning and teaching methods in laboratory sciences; and 3) cognitive strategies in science learning.

Other Positions

  • Assistant Professor, Sociomedical Sciences, Boston University School of Medicine
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences

Classes Taught

  • BT205
  • BT301
  • BT440
  • BT442
  • BT445
  • BT482
  • BT596
  • BT597


  • Published on 4/1/2022

    Coleman F. Preprint Highlight: Pathogenic Neutrophilia Drives Acute Respiratory Distress Syndrome in Severe COVID-19 Patients. Mol Biol Cell. 2022 04 01; 33(4):mbcP22021004. PMID: 35319240.

    Read at: PubMed
  • Published on 1/11/2022

    Murray MP, Crosby CM, Marcovecchio P, Hartmann N, Chandra S, Zhao M, Khurana A, Zahner SP, Clausen BE, Coleman FT, Mizgerd JP, Mikulski Z, Kronenberg M. Stimulation of a subset of natural killer T cells by CD103+ DC is required for GM-CSF and protection from pneumococcal infection. Cell Rep. 2022 01 11; 38(2):110209. PMID: 35021099.

    Read at: PubMed
  • Published on 6/1/2018

    Hartmann N, McMurtrey C, Sorensen ML, Huber ME, Kurapova R, Coleman FT, Mizgerd JP, Hildebrand W, Kronenberg M, Lewinsohn DM, Harriff MJ. Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T Cells. Am J Respir Cell Mol Biol. 2018 06; 58(6):767-776. PMID: 29356555.

    Read at: PubMed
  • Published on 8/15/2017

    Coleman FT, Blahna MT, Kamata H, Yamamoto K, Zabinski MC, Kramnik I, Wilson AA, Kotton DN, Quinton LJ, Jones MR, Pelton SI, Mizgerd JP. Capacity of Pneumococci to Activate Macrophage Nuclear Factor ?B: Influence on Necroptosis and Pneumonia Severity. J Infect Dis. 2017 Aug 15; 216(4):425-435. PMID: 28368460.

    Read at: PubMed
  • Published on 5/17/2017

    Smith NM, Wasserman GA, Coleman FT, Hilliard KL, Yamamoto K, Lipsitz E, Malley R, Dooms H, Jones MR, Quinton LJ, Mizgerd JP. Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. Mucosal Immunol. 2018 Jan; 11(1):220-235. PMID: 28513594.

    Read at: PubMed
  • Published on 10/9/2014

    Hyatt LD, Wasserman GA, Rah YJ, Matsuura KY, Coleman FT, Hilliard KL, Pepper-Cunningham ZA, Ieong M, Stumpo DJ, Blackshear PJ, Quinton LJ, Mizgerd JP, Jones MR. Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection. PLoS One. 2014; 9(10):e109072. PMID: 25299049.

    Read at: PubMed
  • Published on 2/5/2007

    Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun. 2007 Apr; 75(4):1598-608. PMID: 17283089.

    Read at: PubMed
  • Published on 11/1/2004

    Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol. 2004 Nov 1; 173(9):5671-8. PMID: 15494518.

    Read at: PubMed
  • Published on 7/1/2004

    Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, Coutinho YS, Noto MJ, Urban TA, Pier GB, Goldberg JB. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect Immun. 2004 Jul; 72(7):4224-32. PMID: 15213167.

    Read at: PubMed
  • Published on 7/1/2003

    Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun. 2003 Jul; 71(7):3875-84. PMID: 12819072.

    Read at: PubMed

View 5 more publications: View full profile at BUMC

View all profiles